𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor-specific membrane antigens in established cell lines from gliomas

✍ Scribed by T. Wahlström; E. Linder; E. Saksela; B. Westermark


Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
603 KB
Volume
34
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Location of prostate-specific membrane a
✍ Troyer, John K.; Beckett, Mary Lou; Wright, George L. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 836 KB

## Background: Prostate-specific membrane antigen (psma) is a novel prostate biomarker overexpressed in poorly differentiated and metastatic prostate carcinomas and apparently upregulated following hormone-ablation therapy. psma appears to be a satisfactory target for antibody-directed imaging of p

Release of replication-deficient retrovi
✍ Frits Thorsen; Therese Visted; Paulina Lehtolainen; Seppo Ylä-Herttuala; Rolf Bj 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 267 KB 👁 2 views

The present study describes how various growth conditions affect gene expression and virus production from a retroviral packaging cell line (Liz 9), grown as monolayers and as multicellular spheroids. In addition, to study the direct interaction between packaging cells and tumor tissue of glioma ori

Cells from chemically induced mouse sarc
✍ Rondi Walker; Ingegerd Hellstroöm; Karl Erik Hellström 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 367 KB 👁 1 views

## Abstract Tumor‐specific transplantation antigens (TSTA) expressed by cells from transplantable lines of 3‐methyl‐cholanthrene‐induced BALB/c sarcomas were maintained over a 26‐week culture period, which represented 2–32 passages __in vitro__. Cells from __in vitro__‐passaged sarcomas were immuno

Tumor-specific CD8+ T lymphocytes derive
✍ Franck Housseau; Daniel A. Langer; Samuel D. Oberholtzer; Anitha Moorthy; Hyam I 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 150 KB 👁 2 views

## Abstract To identify tumor‐associated antigens as putative targets for developing immunotherapies against prostate cancer, we investigated the ability of T cells derived from the peripheral blood lymphocytes of prostate cancer patients to recognize autologous tumor cells. The technical challenge